Transgene Biotek Limited (TRABI.BO)

INR 7.34

(-0.53%)

Revenue Summary of Transgene Biotek Limited

Transgene Biotek Limited's latest annual revenue in 2023 was 2.34 Million INR , up 326.43% from previous year.
Transgene Biotek Limited's latest quarterly revenue in 2024 Q1 was 492 Thousand INR , up 9.33% from previous quarter.
Transgene Biotek Limited reported a annual revenue of 550.84 Thousand INR in annual revenue 2022, down -36.46% from previous year.
Transgene Biotek Limited reported a annual revenue of 866.94 Thousand INR in annual revenue 2021, down -48.87% from previous year.
Transgene Biotek Limited reported a quarterly revenue of 2.34 Million INR for 2023 FY, up 326.43% from previous quarter.
Transgene Biotek Limited reported a quarterly revenue of 450 Thousand INR for 2023 Q2, down -54.94% from previous quarter.

Annual Revenue Chart of Transgene Biotek Limited (2023 - 2006)

Historical Annual Revenue of Transgene Biotek Limited (2023 - 2006)

Year	Revenue	Revenue Growth
2023	2.34 Million INR	326.43%
2022	550.84 Thousand INR	-36.46%
2021	866.94 Thousand INR	-48.87%
2020	1.69 Million INR	4642.12%
2019	35.75 Thousand INR	-94.98%
2018	712.87 Thousand INR	-39.71%
2017	1.18 Million INR	70.86%
2016	692.02 Thousand INR	-61.88%
2015	1.81 Million INR	-42.33%
2014	3.14 Million INR	-67.92%
2013	9.81 Million INR	-93.47%
2012	150.3 Million INR	-42.75%
2011	262.51 Million INR	163.4%
2010	99.66 Million INR	150.13%
2009	39.84 Million INR	7.69%
2008	37 Million INR	-1.16%
2007	37.43 Million INR	85.0%
2006	20.23 Million INR	0.0%

Year	Revenue	Revenue Growth
2024 Q1	492 Thousand INR	9.33%
2023 FY	2.34 Million INR	326.43%
2023 Q2	450 Thousand INR	-54.94%
2023 Q1	998.71 Thousand INR	652851.63%
2023 Q4	450 Thousand INR	0.0%
2023 Q3	450 Thousand INR	0.0%
2022 FY	550.84 Thousand INR	-36.46%
2022 Q2	- INR	-100.0%
2022 Q3	- INR	0.0%
2022 Q1	550.84 Thousand INR	-35.19%
2022 Q4	-153.00 INR	0.0%
2021 Q4	850 Thousand INR	0.0%
2021 Q1	- INR	-100.0%
2021 FY	866.94 Thousand INR	-48.87%
2021 Q3	- INR	-100.0%
2021 Q2	16.94 Thousand INR	0.0%
2020 FY	1.69 Million INR	4642.12%
2020 Q1	- INR	-100.0%
2020 Q2	- INR	0.0%
2020 Q3	1.56 Million INR	0.0%
2020 Q4	130 Thousand INR	-91.7%
2019 FY	35.75 Thousand INR	-94.98%
2019 Q4	35.75 Thousand INR	0.0%
2019 Q3	- INR	0.0%
2019 Q2	- INR	0.0%
2019 Q1	- INR	100.0%
2018 Q4	-712.87 Thousand INR	0.0%
2018 FY	712.87 Thousand INR	-39.71%
2018 Q3	- INR	0.0%
2018 Q2	- INR	-100.0%
2018 Q1	712.87 Thousand INR	0.0%
2017 FY	1.18 Million INR	70.86%
2016 FY	692.02 Thousand INR	-61.88%
2016 Q4	- INR	0.0%
2015 FY	1.81 Million INR	-42.33%
2015 Q4	- INR	0.0%
2014 FY	3.14 Million INR	-67.92%
2013 FY	9.81 Million INR	-93.47%
2012 Q3	47.13 Million INR	10.63%
2012 Q2	42.6 Million INR	-21.7%
2012 Q1	54.41 Million INR	0.0%
2012 FY	150.3 Million INR	-42.75%
2012 Q4	6.14 Million INR	-86.96%
2011 FY	262.51 Million INR	163.4%
2010 FY	99.66 Million INR	150.13%
2009 FY	39.84 Million INR	7.69%
2008 FY	37 Million INR	-1.16%
2007 FY	37.43 Million INR	85.0%
2006 FY	20.23 Million INR	0.0%

Peer Revenue Comparison of Transgene Biotek Limited

Name	Revenue	Revenue Difference
Alfavision Overseas (India) Limited	31.27 Million INR	92.489%
Biocon Limited	147.55 Billion INR	99.998%
Blue Jet Healthcare Limited	7.11 Billion INR	99.967%
Concord Biotech Limited	10.16 Billion INR	99.977%
Dishman Carbogen Amcis Limited	26.15 Billion INR	99.991%
FERMENTA BIOTECH LIMITED	3.35 Billion INR	99.93%
GENOMIC VALLEY BIOTECH LIMITED	1.65 Million INR	-42.299%
Lyka Labs Limited	1.05 Billion INR	99.777%
Panacea Biotec Limited	5.51 Billion INR	99.957%
SAMSRITA LABS LIMITED	- INR	-Infinity%
Servoteach Industries Limited	- INR	-Infinity%
SMS Lifesciences India Limited	3.05 Billion INR	99.923%
Supriya Lifescience Limited	5.7 Billion INR	99.959%
Syngene International Limited	34.88 Billion INR	99.993%
TAKE Solutions Limited	656.08 Million INR	99.642%
Titan Biotech Limited	1.64 Billion INR	99.857%
Vanta Bioscience Limited	97.22 Million INR	97.584%